ACI Tox Data Q&A: Dr Parveen Bhatarah and Dr Paul Duffy

In this video ACI’s scientific and regulatory experts Dr Parveen Bhatarah and Dr Paul Duffy answer questions relating to the CBD toxicology studies the ACI undertook to meet safety concerns held by the Food Standards Agency and Committee on Toxicity. The questions came from companies operating in the UK CBD sector.

ACI submits tox data to FSA

Compliance CBD novel food

The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]

What rules and regulations govern CBD in the UK?

CBD wholesale compliance

A high-level overview of the regulatory framework governing the three most common categories of CBD products.  Those operating in the consumer arena or the CBD wholesale market should be advised of the web of regulatory tools which lay out the basis for compliant cannabinoids in the UK. CBD is widely available off the shelf via […]

The CBD list in numbers

the CBD list in numbers

Cannabinoid Insight has monitored the various numbers and statements made since the publication of the CBD list by the Food Standards Agency (FSA) in March. Here is how things stand in April 2022, in the weeks after the list went live. Since 1 January 2021, the FSA has received over 900 novel food applications for CBD […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]

New report on THC in the UK makes recommendations for consumer CBD products

A recent report on THC levels in the UK has made a number of recommendations to the Home Office. The cannabinoids, THC, THC-V and CBN are controlled substances under the Misuse of Drugs Act. The Home Office has long maintained a 1mg threshold for controlled cannabinoids in any CBD product designed for consumer use, regardless […]

White labelling: Everything you need to know before launching a CBD brand

Updated 23.09.22 Say you want to add a CBD product to your existing portfolio, or you want to launch a new brand. Have you looked into white labelling? White label services are growing more and more popular in the wellness space, with expert manufacturers making it easier than ever to launch a brand. Having the […]